We used COX analysis to evaluate the effects of multiple variables, including age, tumor location, histological type, tumor grade, tumor stage, tumor size, lymph node metastasis, ER status, PR status, HER2 status, menopause status and S100A8 expression level, on OS and DFS. Here, ESR1 is linked to metastatic malignant neoplasm in the lymph nodes.